Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By activating these https://jonasixpb962845.dgbloggers.com/36712896/retatrutide-a-promising-new-treatment-for-obesity